Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Enterprise Value (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Enterprise Value data on record, last reported at -$74.5 million in Q4 2025.

  • For Q4 2025, Enterprise Value fell 11.08% year-over-year to -$74.5 million; the TTM value through Dec 2025 reached -$74.5 million, down 11.08%, while the annual FY2025 figure was -$77.0 million, 32.78% up from the prior year.
  • Enterprise Value reached -$74.5 million in Q4 2025 per PAHC's latest filing, up from -$85.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$43.8 million in Q3 2021 and bottomed at -$114.6 million in Q2 2024.
  • Average Enterprise Value over 5 years is -$82.0 million, with a median of -$83.3 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: skyrocketed 52.37% in 2021, then tumbled 96.95% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$63.4 million in 2021, then dropped by 23.72% to -$78.4 million in 2022, then decreased by 17.94% to -$92.5 million in 2023, then grew by 27.48% to -$67.1 million in 2024, then decreased by 11.08% to -$74.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$74.5 million in Q4 2025, -$85.3 million in Q3 2025, and -$77.0 million in Q2 2025.